Clinical trial
A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for…
NCT00418678 · Veeda Oncology, Other · Terminated
Key facts
| NCT number | NCT00418678 |
|---|---|
| Title | A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting |
| Official title | A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting |
| Lead sponsor | Veeda Oncology, Other |
| Collaborators | Bausch Health Americas, Inc. Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Nausea and Vomiting |
| Intervention type | Drug |
| Interventions | Cesamet |
| Enrollment | 16 |
| Start date | Aug 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jan 5, 2007 |
| Last update posted | Dec 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: